CDSCO Guidelines for Clinical Trials and Drug Approvals in India: A Complete Overview
As the regulatory arm of the Ministry of Health and Family Welfare, CDSCO ensures that drugs, biologics, and medical devices meet standards of safety, efficacy, and quality. With the introduction of the New Drugs and Clinical Trials Rules, 2019 (NDCTR), India has streamlined its clinical trial approval processes, aiming to align more closely with global standards while maintaining robust patient protections.
Click to read the full article.